Danielle Brooks
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Danielle Brooks has a total of 9 co-authors. Here are the top co-authors by number of shared publications:
Barbara Kamel
Department of Pharmacy, Long Island Jewish Medical Center, Northwell Health, New Hyde Park, NY 11040, USA
1 shared publication- Caitlyn Gordon
Northwell, New Hyde Park, NY and Long Island Jewish Medical Center Department of Pharmacy, New Hyde Park, NY 11040, USA
1 shared publication - Ian Baine
Department of Pathology, Molecular and Cell‐Based Medicine Icahn School of Medicine at Mount Sinai New York New York USA
1 shared publication Lauren McKeon
Department of Pharmacy, Long Island Jewish Medical Center, Northwell Health, New Hyde Park, NY 11040, USA
1 shared publication- Nirali A. Shah
Division of Endocrinology, Diabetes and Bone Disease, Department of Medicine, Icahn School of Medicine at Mount Sinai, New York, New York
1 shared publication Priya Grewal
Division of Liver Diseases and Recanati/Miller Transplantation Institute, Icahn School of Medicine at Mount Sinai, New York, New York
1 shared publication
Latest Publications
- Open Access
- 9 December 2022
- Published by Elsevier in Diabetes Epidemiology and Management
- Vol. 10, 100123
Dexamethasone use and insulin requirements in coronovirus-19 (COVID-19) infection stratified by Hemoglobin A1c
- 9 December 2022
- Published by Elsevier in Diabetes Epidemiology and Management
- Vol. 10, 100123
Open AccessDexamethasone use and insulin requirements in coronovirus-19 (COVID-19) infection stratified by Hemoglobin A1c
- Open Access
- 13 March 2021
- Published by Elsevier in AACE Clinical Case Reports
- Vol. 7 (5) , 307-309
Mycophenolate Mofetil and Plasmapheresis: A Treatment Option for Severe Insulin Resistance caused by Insulin Antibodies
- 13 March 2021
- Published by Elsevier in AACE Clinical Case Reports
- Vol. 7 (5) , 307-309
Open AccessMycophenolate Mofetil and Plasmapheresis: A Treatment Option for Severe Insulin Resistance caused by Insulin Antibodies